G-protein Coupled Receptors (GPCRs): A Potential Target of Apigenin as a Novel hACE2 Receptor Specific Therapeutic for Impeding Lung Cancer Considering a Group of Missense and Nonsense Mutations in COVID-19 Patients. EJPHARMA [Internet]. 2025 May 13 [cited 2025 Oct. 18];5(1):6-15. Available from: https://www.ej-pharma.org/index.php/pharma/article/view/85